Medicenna Therapeutics Corp (MDNA.TO) is having a challenging day on the TSX, with its stock dropping 3.80%.
In the latest trading session, Medicenna's stock price fell to CA$0.38. This decline comes without any significant news to explain it, raising concerns among investors about the company’s future prospects.
Investor takeaway: Investors should be cautious as Medicenna's recent performance may indicate underlying issues, especially given the lack of positive news to support its stock price.
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
Medicenna Therapeutics Corp
MDNA.TO
MDNA.TO
Medicenna Therapeutics Corp
WealthAwesomeMarket cap
$33.23M
52W high
$1.97
52W low
$0.34
1W change
+2.86%
Beta
1.89
Analyst Price Targets
Based on analyst covering MDNA
Wall Street analysts forecast MDNA stock price to rise 788.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$3.20
+788.9% Upside
Current Price
C$0.36
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MDNA's historical volatility
30-Day Vol
34.7%
Annualized
90-Day Vol
67.9%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.30
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.34 | C$0.30 – C$0.38 |
| 60 trading days | C$0.32 | C$0.27 – C$0.38 |
| 90 trading days | C$0.30 | C$0.24 – C$0.37 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Bull case
If Medicenna can effectively use its recent public offerings to fund promising clinical trials, it might regain investor confidence and drive its stock price higher in the long term.
Bear case
Without a clear path to profitability or any significant news, ongoing declines could lead to further pessimism among investors and a potential loss of market interest.
Current Market Performance
Medicenna's stock price dropped by 3.80% in the last trading session, closing at CA$0.38. This decline is particularly concerning given the company’s recent public offerings aimed at raising capital. Investors are left wondering how this will affect future growth and development.
Advertisement
Investor Sentiment
The absence of significant news from Medicenna has created a cautious sentiment among investors. With a market cap of CA$35,074,076, the stock's performance is under close scrutiny. Investors may need to reevaluate their positions in light of the recent downturn. For more details on Medicenna's performance, visit the Wealth Awesome stock page.
Looking Ahead
As Medicenna navigates its financial landscape, the outcomes of its ongoing clinical programs will be crucial. Investors should keep an eye on upcoming announcements, as these could significantly influence the stock's direction. For ongoing updates, check the latest news on MDNA.TO.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
